Arcturus Therapeutics Holdings Inc. · NASDAQ:ARCT
Balyasny Asset Management L.P. reported a 8.04% stake in Arcturus Therapeutics Holdings Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Balyasny Asset Management L.P. reported a 8.04% stake in Arcturus Therapeutics Holdings Inc., 2,183,985 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 8.04%
- Shares
- 2,183,985
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Balyasny Asset Management L.P. | 8.04% | 2,183,985 |
| BAM GP LLC | 8.04% | 2,183,985 |
| Balyasny Asset Management Holdings LP | 8.04% | 2,183,985 |
| Dames GP LLC | 8.04% | 2,183,985 |
| Dmitry Balyasny | 8.04% | 2,183,985 |
Source
Related
- Arcturus Therapeutics Holdings Inc.
- Balyasny Asset Management L.P.
- Arcturus Therapeutics Holdings Inc. shareholders
- Schedule 13G/A · Balyasny Asset Management L.P. · Feb 17, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Oct 7, 2026
- Schedule 13G/A · ARK Investment Management LLC · May 7, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · ARK Investment Management LLC · Feb 3, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Jan 8, 2026